Instil Bio, Inc.
TIL
$15.46
$0.1551.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 46.33M | 48.06M | 49.30M | 50.11M | 50.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.96M | 60.82M | 69.98M | 76.33M | 90.54M |
| Operating Income | -59.96M | -60.82M | -69.98M | -76.33M | -90.54M |
| Income Before Tax | -74.14M | -75.17M | -119.58M | -123.32M | -156.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -74.14 | -75.17 | -119.58 | -123.32 | -156.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.14M | -75.17M | -119.58M | -123.32M | -156.09M |
| EBIT | -59.96M | -60.82M | -69.98M | -76.33M | -90.54M |
| EBITDA | -56.35M | -56.91M | -66.02M | -72.36M | -85.79M |
| EPS Basic | -11.39 | -11.56 | -18.39 | -18.96 | -24.00 |
| Normalized Basic EPS | -5.81 | -5.88 | -6.89 | -7.20 | -8.40 |
| EPS Diluted | -11.39 | -11.56 | -18.39 | -18.96 | -24.00 |
| Normalized Diluted EPS | -5.81 | -5.88 | -6.89 | -7.20 | -8.40 |
| Average Basic Shares Outstanding | 26.04M | 26.02M | 26.02M | 26.02M | 26.02M |
| Average Diluted Shares Outstanding | 26.04M | 26.02M | 26.02M | 26.02M | 26.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |